Search research articles
Contact Us
Filters
Showing results (701-710 of 850) with videos related to
Page
of 85
Sort By:
The Prostate
|
December 20, 2024
The Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Evaluating Prostate Adenocarcinoma: A Partially-Blinded Retrospective Study of a Prostatectomy Patient Cohort With Whole Gland Histopathology Correlation and Application of PI-RADS or TNM Staging
Sajeev Sridhar, Zeyad Abouelfetouh, Ion Codreanu, et al.
Oncogene
|
December 15, 2010
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
I Martins, O Kepp, F Schlemmer, et al.
Zhonghua Yi Xue Za Zhi
|
December 13, 2019
[Clinical characteristics of cardiomyopathies complicated with ventricular thrombosis]
Z C Hu, L M Wu, S Y Liu, et al.
Molecular Systems Biology
|
February 16, 2008
Pairing of competitive and topologically distinct regulatory modules enhances patterned gene expression
Itai Yanai, L Ryan Baugh, Jessica J Smith, et al.
Cell Death and Differentiation
|
July 16, 2013
Molecular mechanisms of ATP secretion during immunogenic cell death
I Martins, Y Wang, M Michaud, et al.
Molecular Psychiatry
|
June 1, 2016
Modeling psychiatric disorders: from genomic findings to cellular phenotypes
A Falk, V M Heine, A J Harwood, et al.
Bioorganic & Medicinal Chemistry
|
January 30, 2002
Synthesis of (bis)sulfonic acid, (bis)benzamides as follicle-stimulating hormone (FSH) antagonists
Jay Wrobel, Daniel Green, James Jetter, et al.
American Journal of Human Genetics
|
August 1, 1996
A locus for Fanconi anemia on 16q determined by homozygosity mapping
M Gschwend, O Levran, L Kruglyak, et al.
Cancer Immunology, Immunotherapy : CII
|
February 1, 1996
Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC
M C Panelli, E Wang, S Shen, et al.
Anticancer Research
|
May 1, 1997
Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer
S J Denardo, C M Richman, D S Goldstein, et al.
Page
of 85
Search research articles
Search
Showing results (701-710 of 850) with videos related to
Sort By:
Page
of 85
The Prostate
|
December 20, 2024
The Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Evaluating Prostate Adenocarcinoma: A Partially-Blinded Retrospective Study of a Prostatectomy Patient Cohort With Whole Gland Histopathology Correlation and Application of PI-RADS or TNM Staging
Sajeev Sridhar, Zeyad Abouelfetouh, Ion Codreanu, et al.
Oncogene
|
December 15, 2010
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
I Martins, O Kepp, F Schlemmer, et al.
Zhonghua Yi Xue Za Zhi
|
December 13, 2019
[Clinical characteristics of cardiomyopathies complicated with ventricular thrombosis]
Z C Hu, L M Wu, S Y Liu, et al.
Molecular Systems Biology
|
February 16, 2008
Pairing of competitive and topologically distinct regulatory modules enhances patterned gene expression
Itai Yanai, L Ryan Baugh, Jessica J Smith, et al.
Cell Death and Differentiation
|
July 16, 2013
Molecular mechanisms of ATP secretion during immunogenic cell death
I Martins, Y Wang, M Michaud, et al.
Molecular Psychiatry
|
June 1, 2016
Modeling psychiatric disorders: from genomic findings to cellular phenotypes
A Falk, V M Heine, A J Harwood, et al.
Bioorganic & Medicinal Chemistry
|
January 30, 2002
Synthesis of (bis)sulfonic acid, (bis)benzamides as follicle-stimulating hormone (FSH) antagonists
Jay Wrobel, Daniel Green, James Jetter, et al.
American Journal of Human Genetics
|
August 1, 1996
A locus for Fanconi anemia on 16q determined by homozygosity mapping
M Gschwend, O Levran, L Kruglyak, et al.
Cancer Immunology, Immunotherapy : CII
|
February 1, 1996
Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC
M C Panelli, E Wang, S Shen, et al.
Anticancer Research
|
May 1, 1997
Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer
S J Denardo, C M Richman, D S Goldstein, et al.
Page
of 85